(Q45100818)

English

Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study

scientific article published in August 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Clinical efficacy of olopatadine hydrochloride ophthalmic solution 0.2% compared with placebo in patients with allergic conjunctivitis or rhinoconjunctivitis: a randomized, double-masked environmental study (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

rhinoconjunctivitis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

allergic conjunctivitis

1 reference

based on heuristic

inferred from title

author name string

Mark B Abelson

1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Paul J Gomes

2

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Cullen T Vogelson

3

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Terri A Pasquine

4

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Robert D Gross

5

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

F Darell Turner

6

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

David T Wells

7

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Michael V W Bergamini

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Stella M Robertson

9

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

1237-1248

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of topical ocular anti-allergy drugs on human conjunctival mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Olopatadine inhibits TNFalpha release from human conjunctival mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Olopatadine (AL-4943A): ligand binding and functional studies on a novel, long acting H1-selective histamine antagonist and anti-allergic agent for use in allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of KW-4679, a new orally active antiallergic drug, on antigen-induced bronchial hyperresponsiveness, airway inflammation and immediate and late asthmatic responses in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

KW-4679, an antiallergic drug, inhibits the production of inflammatory lipids in human polymorphonuclear leukocytes and guinea pig eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibitory effect of olopatadine on antigen-induced eosinophil infiltration and the LFA-1 and Mac-1 expression in eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2980065-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(04)80065-1

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45100818&oldid=2065789051"